General Psychiatry,
Год журнала:
2024,
Номер
37(1), С. e101374 - e101374
Опубликована: Фев. 1, 2024
The
gut
microbiota
is
a
complex
and
dynamic
ecosystem
known
as
the
‘second
brain’.
Composing
microbiota-gut-brain
axis,
its
metabolites
regulate
central
nervous
system
through
neural,
endocrine
immune
pathways
to
ensure
normal
functioning
of
organism,
tuning
individuals’
health
disease
status.
Short-chain
fatty
acids
(SCFAs),
main
bioactive
microbiota,
are
involved
in
several
neuropsychiatric
disorders,
including
depression.
SCFAs
have
essential
effects
on
each
component
axis
In
present
review,
roles
major
(acetate,
propionate
butyrate)
pathophysiology
depression
summarised
with
respect
chronic
cerebral
hypoperfusion,
neuroinflammation,
host
epigenome
neuroendocrine
alterations.
Concluding
remarks
biological
mechanisms
related
will
hopefully
address
clinical
value
microbiota-related
treatments
for
Pharmacological Research,
Год журнала:
2021,
Номер
172, С. 105840 - 105840
Опубликована: Авг. 24, 2021
Emerging
evidence
indicates
that
the
gut
microbiota
play
a
crucial
role
in
bidirectional
communication
between
and
brain
suggesting
microbes
may
shape
neural
development,
modulate
neurotransmission
affect
behavior,
thereby
contribute
to
pathogenesis
and/or
progression
of
many
neurodevelopmental,
neuropsychiatric,
neurological
conditions.
This
review
summarizes
recent
data
on
microbiota-gut-brain
axis
pathophysiology
neuropsychiatric
disorders
including
depression,
anxiety,
schizophrenia,
autism
spectrum
disorders,
Parkinson's
disease,
migraine,
epilepsy.
Also,
involvement
co-existing
with
conditions
is
highlighted.
We
discuss
from
both
vivo
preclinical
experiments
clinical
reports
including:
(1)
studies
germ-free
animals,
(2)
exploring
composition
animal
models
diseases
or
humans,
(3)
evaluating
effects
probiotic,
prebiotic
antibiotic
treatment
as
well
(4)
fecal
transplantation.
JAMA Psychiatry,
Год журнала:
2021,
Номер
78(12), С. 1343 - 1343
Опубликована: Сен. 15, 2021
Evidence
of
gut
microbiota
perturbations
has
accumulated
for
multiple
psychiatric
disorders,
with
signatures
proposed
as
potential
biomarkers.
However,
no
attempts
have
been
made
to
evaluate
the
specificity
these
across
range
conditions.
Molecular Psychiatry,
Год журнала:
2022,
Номер
27(4), С. 1920 - 1935
Опубликована: Фев. 22, 2022
Abstract
The
emerging
understanding
of
gut
microbiota
as
‘metabolic
machinery’
influencing
many
aspects
physiology
has
gained
substantial
attention
in
the
field
psychiatry.
This
is
largely
due
to
overlapping
pathophysiological
mechanisms
associated
with
both
potential
functionality
and
biological
thought
be
underpinning
mental
disorders.
In
this
systematic
review,
we
synthesised
current
literature
investigating
differences
composition
people
major
psychiatric
disorders,
depressive
disorder
(MDD),
bipolar
(BD)
schizophrenia
(SZ),
compared
‘healthy’
controls.
We
also
explored
across
disorders
an
attempt
elucidate
commonalities
microbial
signatures
these
Following
PRISMA
guidelines,
databases
were
searched
from
inception
through
December
2021.
identified
44
studies
(including
a
total
2510
cases
2407
controls)
that
met
inclusion
criteria,
which
24
investigated
MDD,
seven
BD,
15
SZ.
Our
syntheses
provide
no
strong
evidence
for
difference
number
or
distribution
(α-diversity)
bacteria
those
However,
relatively
consistent
reporting
overall
community
(β-diversity)
without
specific
bacterial
taxa
commonly
including
lower
levels
genera
produce
short-chain
fatty
acids
(e.g.
butyrate),
higher
lactic
acid-producing
bacteria,
glutamate
GABA
metabolism.
observed
heterogeneity
regards
methodologies
reporting.
Further
prospective
experimental
research
using
new
tools
robust
guidelines
hold
promise
improving
our
role
brain
health
development
interventions
based
on
modification
microbiota.
Brain Research Bulletin,
Год журнала:
2022,
Номер
182, С. 44 - 56
Опубликована: Фев. 11, 2022
Depression
is
the
most
common
mental
disorder
and
a
leading
cause
of
disability
worldwide.
Despite
abundant
research,
precise
mechanisms
underlying
pathophysiology
depression
remain
elusive.
Accumulating
evidence
from
preclinical
clinical
studies
suggests
that
alterations
in
gut
microbiota,
microbe-derived
short-chain
fatty
acids,
D-amino
acids
metabolites
play
key
role
via
brain–gut–microbiota
axis,
including
neural
immune
systems.
Notably,
axis
might
crucial
susceptibility
versus
resilience
rodents
exposed
to
stress.
Vagotomy
reported
block
depression-like
phenotypes
after
fecal
microbiota
transplantation
"depression-related"
microbiome,
suggesting
vagus
nerve
influences
through
axis.
In
this
article,
we
review
recent
findings
regarding
discuss
its
potential
as
therapeutic
target
for
depression.
Nature Communications,
Год журнала:
2022,
Номер
13(1)
Опубликована: Дек. 6, 2022
Depression
is
one
of
the
most
poorly
understood
diseases
due
to
its
elusive
pathogenesis.
There
an
urgency
identify
molecular
and
biological
mechanisms
underlying
depression
gut
microbiome
a
novel
area
interest.
Here
we
investigate
relation
fecal
diversity
composition
with
depressive
symptoms
in
1,054
participants
from
Rotterdam
Study
cohort
validate
these
findings
Amsterdam
HELIUS
1,539
subjects.
We
association
thirteen
microbial
taxa,
including
genera
Eggerthella,
Subdoligranulum,
Coprococcus,
Sellimonas,
Lachnoclostridium,
Hungatella,
Ruminococcaceae
(UCG002,
UCG003
UCG005),
LachnospiraceaeUCG001,
Eubacterium
ventriosum
Ruminococcusgauvreauiigroup,
family
symptoms.
These
bacteria
are
known
be
involved
synthesis
glutamate,
butyrate,
serotonin
gamma
amino
butyric
acid
(GABA),
which
key
neurotransmitters
for
depression.
Our
study
suggests
that
may
play
role
Cell Metabolism,
Год журнала:
2022,
Номер
34(5), С. 681 - 701.e10
Опубликована: Май 1, 2022
The
microbiota-gut-brain
axis
has
emerged
as
a
novel
target
in
depression,
disorder
with
low
treatment
efficacy.
However,
the
field
is
dominated
by
underpowered
studies
focusing
on
major
depression
not
addressing
microbiome
functionality,
compositional
nature,
or
confounding
factors.
We
applied
multi-omics
approach
combining
pre-clinical
models
three
human
cohorts
including
patients
mild
depression.
Microbial
functions
and
metabolites
converging
onto
glutamate/GABA
metabolism,
particularly
proline,
were
linked
to
High
proline
consumption
was
dietary
factor
strongest
impact
Whole-brain
dynamics
revealed
rich
club
network
disruptions
associated
circulating
proline.
Proline
supplementation
mice
exacerbated
along
microbial
translocation.
Human
microbiota
transplantation
induced
an
emotionally
impaired
phenotype
alterations
GABA-,
proline-,
extracellular
matrix-related
prefrontal
cortex
genes.
RNAi-mediated
knockdown
of
GABA
transporters
Drosophila
mono-association
L.
plantarum,
high
producer,
conferred
protection
against
depression-like
states.
Targeting
may
open
new
windows
for
efficient
treatment.
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(9), С. 4494 - 4494
Опубликована: Апрель 19, 2022
An
emerging
body
of
literature
demonstrates
differences
in
the
gut
microbiome
(GMB)
patients
with
major
depressive
disorder
(MDD)
compared
to
healthy
controls
(HC),
as
well
potential
benefits
prebiotic,
probiotic,
and
synbiotic
treatment.
We
conducted
a
systematic
review
24
observational
studies
(n
=
2817),
19
interventional
trials
1119).
assessed
alpha
diversity,
beta
taxa
abundance
changes
MDD
relative
HC,
effect
prebiotics,
probiotics,
synbiotics
on
symptoms
individuals
clinical
or
subclinical
depression.
observed
no
significant
diversity
but
difference
between
HC.
There
were
fluctuations
specific
Probiotic
synbiotic,
not
treatment
showed
modest
benefit
reducing
over
four
nine
weeks.
The
GMB
profiles
differ
significantly
from
further
are
needed
elucidate
probiotic
treatments
antidepressants
longer
follow-up
before
these
therapies
implemented
into
practice.
Neuroscience & Biobehavioral Reviews,
Год журнала:
2021,
Номер
125, С. 698 - 761
Опубликована: Март 5, 2021
There
is
increasing
knowledge
regarding
the
role
of
microbiome
in
modulating
brain
and
behaviour.
Indeed,
actions
microbial
metabolites
are
key
for
appropriate
gut-brain
communication
humans.
Among
these
metabolites,
short-chain
fatty
acids,
tryptophan,
bile
acid
metabolites/pathways
show
strong
preclinical
evidence
involvement
various
aspects
function
With
identification
neuroactive
modules,
new
predictive
tools
can
be
applied
to
existing
datasets.
We
identified
278
studies
relating
human
microbiota-gut-brain
axis
which
included
sequencing
data.
This
spanned
across
psychiatric
neurological
disorders
with
a
small
number
also
focused
on
normal
behavioural
development.
consistent
bioinformatics
pipeline,
thirty-five
datasets
were
reanalysed
from
publicly
available
raw
files
remainder
summarised
collated.
studies,
we
uncovered
disease-related
alterations
metabolic
pathways
Alzheimer's
Disease,
schizophrenia,
anxiety
depression.
Amongst
that
could
not
reanalysed,
many
technical
limitations
hindered
discovery
specific
biomarkers
microbes
or
conserved
studies.
Future
warranted
confirm
our
findings.
propose
guidelines
future
analysis
increase
reproducibility
consistency
within
field.